Form 4: Procter & Gamble Director Christine M. McCarthy Reports Acquisition of Common Stock
SEC Form 4 Filing
Director Christine M. McCarthy reported acquiring 1,309 shares of Procter & Gamble common stock on October 8, 2024.
Summary
- On October 9, 2024, a Form 4 filing was submitted to the SEC regarding Christine M. McCarthy, a director of Procter & Gamble Co.
- The report details a transaction on October 8, 2024, where McCarthy acquired 1,309 shares of common stock at a price of $0.
- Following the transaction, McCarthy beneficially owns 13,712.1456 shares of Procter & Gamble common stock directly.
- The acquisition was related to restricted stock units awarded under the company's 2019 Stock & Incentive Compensation Plan.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine disclosure of stock acquisition, which doesn't inherently indicate positive or negative sentiment, but insider buying is generally viewed as a positive sign.
Positives
- The acquisition of shares by a director can be seen as a positive signal, indicating confidence in the company's future performance.
Industry Context
Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. These filings are closely watched by investors to gauge sentiment and potential future actions of key personnel.
Stakeholder Impact
- The acquisition of shares by a director could have a slightly positive impact on shareholder confidence.
Key Dates
| Date | Description |
|---|---|
| 10/08/2024 | Date of transaction: Acquisition of 1,309 shares of common stock. |
| 10/09/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.